SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 60 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $12,328,000 | +80.4% | 4,638,000 | +23.7% | 0.00% | +50.0% |
Q4 2014 | $6,833,000 | -70.9% | 3,748,000 | -61.3% | 0.00% | -66.7% |
Q3 2014 | $23,443,000 | -0.3% | 9,692,000 | -19.0% | 0.01% | 0.0% |
Q2 2014 | $23,503,000 | +157.9% | 11,972,000 | +122.2% | 0.01% | +100.0% |
Q1 2014 | $9,112,000 | -53.9% | 5,389,000 | -59.4% | 0.00% | -50.0% |
Q4 2013 | $19,780,000 | +3.8% | 13,270,000 | -14.6% | 0.01% | 0.0% |
Q3 2013 | $19,059,000 | -1.6% | 15,535,000 | -4.3% | 0.01% | 0.0% |
Q2 2013 | $19,362,000 | – | 16,228,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TENOR CAPITAL MANAGEMENT Co., L.P. | 36,001,000 | $95,697,000 | 16.53% |
CAPSTONE INVESTMENT ADVISORS, LLC | 145,320,992 | $386,133,000 | 6.28% |
Verition Fund Management LLC | 18,500,000 | $49,268,000 | 5.72% |
PIPER SANDLER & CO. | 3,750,000 | $9,968,000 | 4.14% |
BERKLEY W R CORP | 25,881,000 | $68,886,000 | 3.58% |
WOLVERINE ASSET MANAGEMENT LLC | 31,256,000 | $83,048,000 | 1.66% |
TT INTERNATIONAL | 760,000 | $2,020,000 | 1.41% |
FARALLON CAPITAL MANAGEMENT LLC | 31,014,000 | $82,372,000 | 1.20% |
CSS LLC/IL | 8,300,000 | $22,057,000 | 1.12% |
SG Americas Securities, LLC | 370,000 | $98,536,000 | 0.59% |